General Session: Global developments in high-containment level research

“Indonesia plans avian flu laboratory…” “Biosafety facility fails CDC inspections…” “Staffing shortage slows infectious disease research” ... Jonathan Richmond provides national and global perspective on where biocontainment-level research is headed, and how we can get there safely. He surveys the biocontainment research efforts in developing countries, and their impact on worldwide programs. Jonathan shares insights on how facilities must excel in lab design and workplace operations to ensure safety and respond to public scrutiny. He analyzes the expected impact from events such as Pirbright and Texas A&M, and from congressional oversight hearings of the RBL program.

• Jonathan Y. Richmond, PhD , CEO - Jonathan Richmond & Associates, Inc.